Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms, Genomenon Team on Analytics for Rare Disease Dx, Research

NEW YORK – BC Platforms and Genomenon said Tuesday that they have agreed to combine their technologies for rare disease diagnostics and research.

The collaboration calls on Genomenon to integrate its Mastermind genomic search engine into two BC Platforms products: the BC|Genome genomic interpretation and analysis platform to support molecular diagnostics and other forms of clinical genomics; and discovery and insight system BC|Insight on the research side. Mastermind accelerates variant interpretation with the help of machine learning.

"Genomenon is a natural partner for us, as both companies are passionate about powering evidence-based genomics," BC Platforms CEO Tero Silvola said in a statement. "This is about super-charging data-driven decision-making in healthcare."

Further terms of the alliance were not disclosed.